These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38131633)

  • 21. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients.
    Nakahara T; Hyogo H; Yoneda M; Sumida Y; Eguchi Y; Fujii H; Ono M; Kawaguchi T; Imajo K; Aikata H; Tanaka S; Kanemasa K; Fujimoto K; Anzai K; Saibara T; Sata M; Nakajima A; Itoh Y; Chayama K; Okanoue T;
    J Gastroenterol; 2014 Nov; 49(11):1477-84. PubMed ID: 24277052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
    Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
    J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease.
    Maleki I; Aminafshari MR; Taghvaei T; Hosseini V; Rafiei A; Torabizadeh Z; Barzin M; Orang E
    World J Gastroenterol; 2014 Sep; 20(35):12566-73. PubMed ID: 25253959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis.
    Lu S; Xie Q; Kuang M; Hu C; Li X; Yang H; Sheng G; Xie G; Zou Y
    J Transl Med; 2023 Mar; 21(1):192. PubMed ID: 36915168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of weight-adjusted-waist index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study based on NHANES.
    Hu Q; Han K; Shen J; Sun W; Gao L; Gao Y
    Eur J Med Res; 2023 Aug; 28(1):263. PubMed ID: 37537679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of serum uric acid-to-high-density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease in American adults: a population-based analysis.
    Xie Y; Huang K; Zhang X; Wu Z; Wu Y; Chu J; Kong W; Qian G
    Front Med (Lausanne); 2023; 10():1164096. PubMed ID: 37256087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease.
    Lefere S; Van de Velde F; Devisscher L; Bekaert M; Raevens S; Verhelst X; Van Nieuwenhove Y; Praet M; Hoorens A; Van Steenkiste C; Van Vlierberghe H; Lapauw B; Geerts A
    Int J Obes (Lond); 2017 Aug; 41(8):1207-1213. PubMed ID: 28461687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
    Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
    Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
    [No Abstract]   [Full Text] [Related]  

  • 30. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
    Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
    Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey.
    Wong RJ; Liu B; Bhuket T
    Aliment Pharmacol Ther; 2017 Nov; 46(10):974-980. PubMed ID: 28914448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follicle-stimulating hormone is negatively associated with nonalcoholic fatty liver disease in a Chinese elderly population: a retrospective observational study.
    Li X; Xin N; Guo T; Wu Z; Zheng Y; Lin L; Li Q; Lin F
    BMC Endocr Disord; 2023 Aug; 23(1):165. PubMed ID: 37550673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
    Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011-2016).
    Reja D; Makar M; Visaria A; Karanfilian B; Rustgi V
    Ann Hepatol; 2020; 19(4):404-410. PubMed ID: 32376236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population.
    Mikami K; Endo T; Sawada N; Igarashi G; Kimura M; Hasegawa T; Iino C; Tomita H; Sawada K; Nakaji S; Matsuzaka M; Torok NJ; Fukuda S
    Cytokine; 2020 Feb; 126():154927. PubMed ID: 31756645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents.
    Lawlor DA; Callaway M; Macdonald-Wallis C; Anderson E; Fraser A; Howe LD; Day C; Sattar N
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E410-7. PubMed ID: 24471572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV.
    Milic J; Menozzi V; Schepis F; Malagoli A; Besutti G; Franconi I; Raimondi A; Carli F; Mussini C; Sebastiani G; Guaraldi G
    AIDS; 2020 Nov; 34(13):1915-1921. PubMed ID: 33009010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III.
    Reja M; Makar M; Visaria A; Marino D; Rustgi V
    Ann Hepatol; 2020; 19(6):635-640. PubMed ID: 32745632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004.
    Li L; Huang Q; Yang L; Zhang R; Gao L; Han X; Ji L; Zou X
    Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults.
    Yang N; Lu Y; Cao L; Lu M
    J Clin Lab Anal; 2022 Feb; 36(2):e24225. PubMed ID: 34997649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.